Bioharvest Sciences (BHST) Liabilities and Shareholders Equity (2023 - 2025)

Bioharvest Sciences' Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $47.7 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 90.65% year-over-year to $47.7 million; the TTM figure through Dec 2025 stood at $137.2 million (up 33.45% YoY), while the FY2025 annual figure was $47.7 million, up 90.65% from the prior year.
• Liabilities and Shareholders Equity was $47.7 million for Q4 2025 at Bioharvest Sciences, up from $35.2 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $47.7 million in Q4 2025 to a low of $15.0 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $28.3 million across 3 years, with a median of $26.6 million in 2025.
• Biggest YoY gain for Liabilities and Shareholders Equity was 90.65% in 2025; the steepest drop was 2.9% in 2025.
• A 3-year view of Liabilities and Shareholders Equity shows it stood at $15.0 million in 2023, then surged by 66.65% to $25.0 million in 2024, then soared by 90.65% to $47.7 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $47.7 million (Q4 2025), $35.2 million (Q3 2025), and $27.8 million (Q2 2025), per Business Quant data.